Home › NDC Lookup › RxCUI directory › RxCUI 389230

Tamoxifen 2 MG/ML Oral Solution — RxCUI 389230

RxNorm drug concept · Semantic clinical drug
RxCUI 389230 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI389230
Official nameTamoxifen 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astamoxifen 10 MG per 5 ML Oral Solution; tamoxifen citrate 10 MG in 5 mL Oral Solution; tamoxifen 10 MG (as tamoxifen citrate 15.2 MG) per 5 ML Oral Solution
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tamoxifen: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That depends on your situation. Tamoxifen is used for a few related but different reasons: treating breast cancer that has spread, helping prevent breast cancer from coming back af...
  • What exactly is tamoxifen being used for in my case?
  • For most uses — including after surgery for breast cancer, after DCIS treatment, and for high-risk risk reduction — the standard course is 5 years of daily treatment. Soltamox is a...
  • Hot flashes are the most common thing people notice — they can range from mild to pretty disruptive. Vaginal discharge, irregular periods, nausea, and fatigue are also common. Thes...
📖 Read our full Tamoxifen guide →

🕸️ Concept Web — How Tamoxifen 2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tamoxifen 2 MG/ML Oral Solution RxCUI 389230

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tamoxifen 10324
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Soltamox 498464
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tamoxifen Oral Solution 393416
    • Tamoxifen Oral Liquid Product 1164213
    • Tamoxifen Oral Product 1164214
    • Tamoxifen Oral Solution [Soltamox] 644303
    • Soltamox Oral Liquid Product 1184837
    • Soltamox Oral Product 1184838
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tamoxifen 2 MG/ML SCDC · 393415
  • Tamoxifen Oral Solution SCDF · 393416
  • Tamoxifen Oral Liquid Product SCDG · 1164213
  • Tamoxifen Oral Product SCDG · 1164214

Brand-Name Concepts

  • Tamoxifen 2 MG/ML Oral Solution [Soltamox] SBD · 644304
  • Tamoxifen 2 MG/ML [Soltamox] SBDC · 644302
  • Tamoxifen Oral Solution [Soltamox] SBDF · 644303
  • Soltamox Oral Liquid Product SBDG · 1184837
  • Soltamox Oral Product SBDG · 1184838
  • Soltamox BN · 498464

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 389230 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51862-0682-00 1 CONTAINER in 1 CARTON (51862-682-00) / 150 mL in 1 CONTAI... SOLTAMOX Mayne Pharma 2021-12-06
51862-0682-01 1 CONTAINER in 1 CARTON (51862-682-01) / 150 mL in 1 CONTAI... SOLTAMOX Mayne Pharma 2021-06-18
Observed labelers: Mayne Pharma (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$4.4010
Range $4.4010–$4.4010 · middle 50% $4.4010–$4.4010 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.